The cellular and molecular basis of the Lyt‐1+2−T cell‐mediated tumor‐eradicating mechanismin vivo
作者:
Hiromi Fujiwara,
Toshiyuki Hamaoka,
期刊:
BioEssays
(WILEY Available online 1986)
卷期:
Volume 4,
issue 1
页码: 19-23
ISSN:0265-9247
年代: 1986
DOI:10.1002/bies.950040106
出版商: Wiley Subscription Services, Inc., A Wiley Company
数据来源: WILEY
摘要:
AbstractThis article reviews recent findings that bear on the mechanism(s) of tumor‐specific Lyt‐1+2−T cell‐mediated tumor eradication in vivo A tumor‐immune Lyt‐1+2−T cell subset has been identified which is distinct from T cells mediating in vitro cytotoxicity (Lyt‐1+2+/1−2+). The Lyt‐1+2−cells have a crucial role in rejecting tumor cells when adoptively transferred into T cell‐deprived B cell mice. This indicates that Lyt‐1+2−T cells do not necessarily require recruitment of the host's cytotoxic T cell precursors for implementation of in vivo immunity. Instead, this T cell subset exerts its anti‐tumor effect in collaboration with macrophages as shown with an in vivo tumor cell culture system utilizing a diffusion chamber. A pathway of Lyt‐1+2−T cell‐macrophage interaction leading to tumor cell killing is discussed in terms of its probable relevance to the eradication of tumor cell masses consisting of tumor cells expressing quantitatively and/or qua
点击下载:
PDF
(628KB)
返 回